BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 30835718)

  • 1. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNAs in diabetic kidney disease: case-control study and in silico analyses.
    Assmann TS; Recamonde-Mendoza M; Costa AR; Puñales M; Tschiedel B; Canani LH; Bauer AC; Crispim D
    Acta Diabetol; 2019 Jan; 56(1):55-65. PubMed ID: 30167868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.
    Wang J; Wang G; Liang Y; Zhou X
    J Diabetes Res; 2019; 2019():5204394. PubMed ID: 31218232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease.
    Han LL; Wang SH; Yao MY; Zhou H
    World J Diabetes; 2024 Jan; 15(1):92-104. PubMed ID: 38313849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
    Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
    Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease.
    Xie Y; Jia Y; Cuihua X; Hu F; Xue M; Xue Y
    J Diabetes Res; 2017; 2017():6978984. PubMed ID: 29038788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis.
    Assmann TS; Recamonde-Mendoza M; de Souza BM; Bauer AC; Crispim D
    Mol Cell Endocrinol; 2018 Dec; 477():90-102. PubMed ID: 29902497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
    Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
    J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Expression Profiling in Diabetic Kidney Disease.
    Ishii H; Kaneko S; Yanai K; Aomatsu A; Hirai K; Ookawara S; Morishita Y
    Transl Res; 2021 Nov; 237():31-52. PubMed ID: 34102327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis.
    Cosar E; Mamillapalli R; Ersoy GS; Cho S; Seifer B; Taylor HS
    Fertil Steril; 2016 Aug; 106(2):402-9. PubMed ID: 27179784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.
    Liang Z; Gao KP; Wang YX; Liu ZC; Tian L; Yang XZ; Ding JY; Wu WT; Yang WH; Li YL; Zhang ZB; Zhai RH
    Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E374-E385. PubMed ID: 29812988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA expression profiles in healthy OSAHS and OSAHS with arterial hypertension: potential diagnostic and early warning markers.
    Yang X; Niu X; Xiao Y; Lin K; Chen X
    Respir Res; 2018 Oct; 19(1):194. PubMed ID: 30285853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease.
    Beltrami C; Simpson K; Jesky M; Wonnacott A; Carrington C; Holmans P; Newbury L; Jenkins R; Ashdown T; Dayan C; Satchell S; Corish P; Cockwell P; Fraser D; Bowen T
    Am J Pathol; 2018 Sep; 188(9):1982-1992. PubMed ID: 29981742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miRNAs in Type 2 Diabetic Patients with and without Albuminuria in Malaysia.
    Zahari Sham SY; Ng CT; Azwar S; Yip WK; Abdullah M; Thevandran K; Osman M; Seow HF
    Kidney Blood Press Res; 2022; 47(2):81-93. PubMed ID: 35158353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.